International differences in cancer survival rates: the role of new drug launches

Full text for this resource is not available from the Research Repository.

Lichtenberg, Frank R (2009) International differences in cancer survival rates: the role of new drug launches. International Journal of Healthcare Technology and Management, 10 (3). pp. 138-155. ISSN 1368-2156


We investigate the effect of availability of new drugs on survival from 17 types of cancer in 38 countries, controlling for all determinants of cancer survival that are invariant across cancer types within a given country, and that are invariant across countries for a given cancer type. We find that an increase in the number of available drugs is associated with an increase in both the one-year and the five-year survival rate. Also, the probability that a cancer drug has been launched in a country depends on the incidence of cancer cases eligible for treatment by that drug in that country.

Item type Article
Subjects Historical > FOR Classification > 1117 Public Health and Health Services
Historical > FOR Classification > 1402 Applied Economics
Historical > SEO Classification > 9204 Public Health (excl. Specific Population Health)
Historical > Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
Keywords ResPubID17923, cancer survival rates, longevity, pharmaceuticals, innovation, drug launches, new drugs, neoplasm, international differences, cancer drugs
Citations in Scopus 5 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login